Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03393845
Brief Title: Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients

First Submitted : January 2, 2018
First Submitted that Met QC Criteria : January 3, 2018
First Posted : January 9, 2018

Last Update Submitted that Met QC Criteria : July 14, 2021
Last Update Posted : July 16, 2021